Market Trends of Bariatric Surgery Devices Industry
The Assisting Devices segment is Expected to Hold a Major Market Share in the Bariatric Surgery Devices Market
The assisting devices are expected to hold a dominating share in the studied market during the forecast period. This is mainly due to the increasing prevalence of the obese population across the globe, leading to the demand for bariatric surgery devices, thereby propelling the market's growth. Various factors, such as unhealthy habits or lack of physical activity, cause obesity. For instance, the World Health Organization (WHO) published in 2021 that modifiable behavioral risk factors such as tobacco use account for over 7.2 million deaths yearly, and 1.6 million deaths annually can be attributed to insufficient physical activity in the United States.
Additionally, increasing innovative launches to simplify surgeries are expected to drive the market's growth. For instance, in July 2022, the United States FDA provided de novo authorization for Apollo Endosurgery to market its Apollo ESG and Apollo REVISE endoscopic systems for the treatment of patients with obesity. With such new launches, the segment studied is expected to grow considerably during the forecast period.
Furthermore, in September 2021, Olympus launched the POWERSEAL advanced bipolar surgical energy devices to strengthen its surgical portfolio. The POWERSEAL devices can be used in numerous forms of surgical intervention, including bariatric surgical procedures.
Thus, due to the new launches and rising prevalence of obesity, the assisting devices segment is expected to propel over the forecast period.
North America is Expected to Hold a Significant Share in the Market
The market for bariatric surgery devices in the United States is driven by the increasing use of advanced technology in healthcare systems and the country's rising burden of chronic diseases. The major factors attributing to the market growth include a sedentary lifestyle, lack of physical activity, lack of proper diet, anxiety, and stress resulting in chronic diseases such as diabetes and obesity. For instance, in 2022, the CDC mentioned that more than 795,000 people in the United States have a stroke yearly. About 610,000 of these are first or new strokes. To avoid the further complications associated with obesity, there is a growing demand for bariatric surgeries across the region.
As per the United States National Health Statistics Reports published in June 2021, obesity was 41.9%, severe obesity was 9.2%, and diabetes was 14.8% among adults aged 20 and over. The increase in the prevalence of obesity among the population is expected to drive the bariatric surgery market in the United States.
Moreover, product launches by the key market players in the region are expected to boost market growth. For instance, in May 2021, Standard Bariatrics announced the launch of its novel Titan SGS stapling technology, specifically designed for bariatric sleeve surgery. Also, the device has been cleared by the FDA. These new product launches by major players for new closure devices propel the studied market's growth. Similarly, in June 2021, Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched the ENSEAL X1 Curved Jaw Tissue Sealer for colorectal, gynecological, bariatric surgery, and thoracic procedures. These new product launches by major players for new closure devices propel the studied market's growth.
Thus, due to the factors mentioned above, the market is expected to witness a boost in growth in this region during the forecast period.
